Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | MRNA | GH | ||
| Company | Ascendis Pharma ADR | Moderna Inc | Guardant Health Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 211.00 | 40.12 | 108.00 | ||
| High | 222.99 | 40.91 | 108.51 | ||
| Low | 211.00 | 38.82 | 100.28 | ||
| Latest | 218.10 | 40.11 | 102.76 | ||
| Change | -3.39 | -0.40 | -4.82 | ||
| % Change | -1.53% | -0.99% | -4.48% | ||
| Volume | 1,684,400 | 7,904,600 | 2,006,100 | ||
| 20-Day Average Volume | 761,835 | 13,227,970 | 2,046,895 | ||
| Previous Close | 221.49 | 40.51 | 107.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 222.77 | 43.91 | 110.27 | ||
| 20-Day Raw Stochastic | 42.15% | 18.63% | 22.57% | ||
| 20-Day Relative Strength | 50.24 | 52.20 | 46.35 | ||
| Weighted Alpha | +47.05 | +38.24 | +94.73 | ||
| Today's Opinion | 88% Buy | 88% Buy | 56% Buy | ||
| Previous Opinion | 88% Buy | 88% Buy | 72% Buy | ||
| Last Month's Opinion | 96% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.33% since 02/05/26 | -1.86% since 02/05/26 | +4.47% since 02/05/26 | ||
| Low | 211.00 on 02/12/26 | 36.65 on 02/11/26 | 97.52 on 02/06/26 | ||
| High | 226.40 on 02/09/26 | 45.50 on 02/10/26 | 108.51 on 02/12/26 | ||
| 1-Month | |||||
| %Chg | +4.47% since 01/12/26 | +18.53% since 01/12/26 | -4.47% since 01/12/26 | ||
| Low | 200.68 on 01/20/26 | 34.05 on 01/13/26 | 97.52 on 02/06/26 | ||
| High | 242.00 on 01/28/26 | 55.20 on 01/22/26 | 120.74 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +9.48% since 11/12/25 | +50.17% since 11/12/25 | +5.03% since 11/12/25 | ||
| Low | 188.07 on 11/13/25 | 22.28 on 11/21/25 | 90.43 on 11/14/25 | ||
| High | 242.00 on 01/28/26 | 55.20 on 01/22/26 | 120.74 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +11.29% since 08/12/25 | +56.31% since 08/12/25 | +86.50% since 08/12/25 | ||
| Low | 186.05 on 10/20/25 | 22.28 on 11/21/25 | 53.40 on 09/16/25 | ||
| High | 242.00 on 01/28/26 | 55.20 on 01/22/26 | 120.74 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,727,286 | 15,828,634 | 13,559,491 | ||
| Shares Outstanding, K | 61,977 | 390,734 | 126,041 | ||
| Annual Sales | 393,500,000 | 3,236,000,000 | 739,020,000 | ||
| Annual Net Income | -409,120,000 | -3,561,000,000 | -436,370,000 | ||
| Last Quarter Sales | 249,720,000 | 1,016,000,000 | 265,200,000 | ||
| Last Quarter Net Income | -71,290,000 | -200,000,000 | -92,730,000 | ||
| 60-Month Beta | 0.44 | 1.32 | 1.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.17 on 11/12/25 | -0.51 on 11/06/25 | -0.39 on 10/29/25 | ||
| Latest Earnings Date | 05/07/26 | 02/13/26 | 02/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||